Current Assets
Cash & Equivalents
Intuitive Surgical Cash & Equivalents decreased by 39.8% to $2.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.6%, from $2.62B to $2.05B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 15.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2012
Last reportedQ1 2026Apr 22, 2026
How to read this metric
An increase suggests strong liquidity and potential for future investment, while a decrease may indicate heavy capital expenditure or cash burn.
Detailed definition
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term invest...
Peer comparison
High levels are common in mature medical technology firms to support R&D and potential M&A activity.
Metric ID:
cash_and_equivalentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.36B | $1.31B | $1.12B | $1.55B | $1.55B | $1.60B | $2.17B | $3.46B | $3.62B | $2.77B | $2.87B | $3.07B | $2.45B | $2.06B | $2.62B | $3.45B | $2.85B | $3.41B | $2.05B |
| QoQ Change | — | -16.5% | -4.1% | -14.4% | +38.7% | +0.2% | +3.0% | +35.3% | +59.6% | +4.8% | -23.5% | +3.5% | +7.0% | -20.2% | -15.7% | +26.9% | +31.7% | -17.3% | +19.6% | -39.8% |
| YoY Change | — | — | — | — | -4.9% | +14.1% | +22.6% | +93.7% | +122.9% | +133.1% | +73.1% | +32.4% | -11.3% | -32.5% | -25.5% | -8.7% | +12.4% | +16.5% | +65.2% | -21.6% |
Range$1.12B – $3.62B
CAGR+5.0%
Avg YoY Growth+30.1%
Median YoY Growth+15.3%
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Intuitive Surgical's cash & equivalents?
- Intuitive Surgical (ISRG) reported cash & equivalents of $2.05B in Q1 2026.
- How has Intuitive Surgical's cash & equivalents changed year-over-year?
- Intuitive Surgical's cash & equivalents decreased by 21.6% year-over-year, from $2.62B to $2.05B.
- What is the long-term trend for Intuitive Surgical's cash & equivalents?
- Over 5 years (2020 to 2025), Intuitive Surgical's cash & equivalents has grown at a 15.8% compound annual growth rate (CAGR), from $1.64B to $3.41B.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid investments the company can access immediately.